To address this knowledge gap, the study aimed to investigate how FTO affects the malignant biological behavior and aerobic glycolytic metabolism of colon cancer by regulating the expression of PKM2, focusing on the perspective of energy metabolism. The gene discussed is PKM; the disease is malignant colon neoplasm.